Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma

Leuk Lymphoma. 2019 Dec;60(14):3577-3580. doi: 10.1080/10428194.2019.1633639. Epub 2019 Jul 8.

Authors

Affiliations

¹ Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
² Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.

PMID: 31282234
DOI: 10.1080/10428194.2019.1633639

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Combined Modality Therapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Leukemia, Myeloid / etiology
Leukemia, Myeloid / mortality*
Leukemia, Myeloid / pathology
Male
Multiple Myeloma / pathology
Multiple Myeloma / therapy*
Myelodysplastic Syndromes / etiology
Myelodysplastic Syndromes / mortality*
Myelodysplastic Syndromes / pathology
Myeloproliferative Disorders / etiology
Myeloproliferative Disorders / mortality*
Myeloproliferative Disorders / pathology
Neoplasms, Second Primary / etiology
Neoplasms, Second Primary / mortality*
Neoplasms, Second Primary / pathology
Prognosis
Retrospective Studies
Survival Rate